T1	Outcomes 1340 1362	Serious adverse events
T2	Outcomes 1376 1392	gastrointestinal
T3	Outcomes 1406 1417	hematologic
T4	Outcomes 1517 1549	antibody responses against ALVAC
T5	Outcomes 1565 1589	anti-CEA antibody titers
T6	Outcomes 1641 1661	CEA-specific T cells
T7	Outcomes 2048 2077	CEA-specific T-cell responses
